FRI is pleased to announce that Dr. Mishka Terplan has accepted the position of Senior Physician Research Scientist at FRI. Dr. Terplan is a physician who is Board Certified in both Obstetrics & Gynecology and Addiction Medicine. His primary clinical, research and advocacy interests rest along the intersection of reproductive and behavioral health. He is […]
In July of 2019, the Baltimore Sun Editorial Board published an article entitled, “Maryland can stop black market suboxone in prisons by making it available to inmates.” The article cited two of Dr. Michael Gordon’s ongoing National Institute on Drug Abuse funded studies: (1) Long-acting naltrexone for pre-release prisoners: A randomized trial of mobile treatment; […]
FRI is pleased to announce that Dr. Thomas R. Blue has been promoted from an Assistant Research Scientist to a Research Scientist, effective July 17, 2019. Since joining FRI in 2017, Dr. Blue has performed several secondary analyses of research data including analyses of arrest outcomes (now published in the Journal of Drug and Alcohol Dependence) and […]
MAXINE L. STITZER, Ph.D. Professor Emerita of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine Dr. Stitzer was a founding faculty member of the Behavioral Pharmacology Research Unit, a nationally recognized substance abuse research laboratory within the Department of Psychiatry at Johns Hopkins School of Medicine. Her research interests during a successful 40+ year career […]
FRI is pleased to announce that Dr. Mary Mitchell has been promoted from an Assistant Research Scientist to a Research Scientist, effective January, 2019. Dr. Mitchell joined FRI in September 2017. Since that time, she has contributed to a number of studies conducted at FRI while pursuing her own research. She will be serving as […]
FRI is pleased to announce that Dr. Jan Gryczynski, along with Co-Investigators Drs. Robert Schwartz, Shannon Mitchell, and Kathleen Page have received a grant award from the National Institute on Drug Abuse, entitled Opioid Use Disorder Treatment Linkage at STD Clinics using Buprenorphine (OUTLAST-B). Untreated opioid use disorder (OUD) is a continuing public health emergency […]
Dr. Thomas Blue has been awarded a Junior Investigator scholarship by the Academic Consortium on Criminal Justice Health to attend their conference held in Las Vegas, Nevada in March of 2019. The award will provide support for travel expenses and cover the costs of registration and lodging. Dr. Blue is planning to present preliminary findings […]
FRI is pleased to announce that Dr. Kimberly Kisler, along with Co-Investigator Dr. Cathy J. Reback, have received a three-year grant from Health Resources and Services Administrations’ Special Projects of National Significance entitled, “Adaptation of an Evidence-informed Behavioral Health Intervention to Improve Health Outcomes among Black Men who have Sex with Men (BMSM) Living with […]
FRI is pleased to announce that Dr. Laura Monico has been promoted from an Assistant Research Scientist to a Research Scientist, effective September 1, 2018. Since joining FRI in 2014, Dr. Monico has primarily worked on three NIDA-funded studies that investigate various dimensions of pharmacotherapy and has authored publications from several more. Over the past […]
